1261 related articles for article (PubMed ID: 10603619)
1. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
Barkhof F; van Walderveen M
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
[TBL] [Abstract][Full Text] [Related]
2. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance imaging in multiple sclerosis].
Tourbah A; Berry I
Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
Zhou F; Shiroishi M; Gong H; Zee CS
J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
[TBL] [Abstract][Full Text] [Related]
7. [MRI visualization of multiple sclerosis lesions].
Berry I; Ranjeva JP; Manelfe C; Clanet M
Rev Neurol (Paris); 1998 Sep; 154(8-9):607-17. PubMed ID: 9809376
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
9. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
Filippi M; Agosta F
Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
[TBL] [Abstract][Full Text] [Related]
11. Correlations between magnetization transfer metrics and other magnetic resonance abnormalities in multiple sclerosis.
Rovaris M; Horsfield MA; Filippi M
Neurology; 1999; 53(5 Suppl 3):S40-5. PubMed ID: 10496210
[TBL] [Abstract][Full Text] [Related]
12. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
13. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
[TBL] [Abstract][Full Text] [Related]
14. [Magnetic resonance imaging in multiple sclerosis].
Saida T
Rinsho Shinkeigaku; 1999 Jan; 39(1):114-5. PubMed ID: 10377832
[TBL] [Abstract][Full Text] [Related]
15. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
16. Magnetization transfer imaging to monitor the evolution of individual multiple sclerosis lesions.
Filippi M
Neurology; 1999; 53(5 Suppl 3):S18-22. PubMed ID: 10496206
[TBL] [Abstract][Full Text] [Related]
17. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
Santos AC; Narayanan S; de Stefano N; Tartaglia MC; Francis SJ; Arnaoutelis R; Caramanos Z; Antel JP; Pike GB; Arnold DL
J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296
[TBL] [Abstract][Full Text] [Related]
18. MRI relapses have significant pathologic and clinical implications in multiple sclerosis.
Traboulsee A
J Neurol Sci; 2007 May; 256 Suppl 1():S19-22. PubMed ID: 17346748
[TBL] [Abstract][Full Text] [Related]
19. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.
Molyneux PD; Filippi M; Barkhof F; Gasperini C; Yousry TA; Truyen L; Lai HM; Rocca MA; Moseley IF; Miller DH
Ann Neurol; 1998 Mar; 43(3):332-9. PubMed ID: 9506550
[TBL] [Abstract][Full Text] [Related]
20. Black holes in multiple sclerosis: definition, evolution, and clinical correlations.
Sahraian MA; Radue EW; Haller S; Kappos L
Acta Neurol Scand; 2010 Jul; 122(1):1-8. PubMed ID: 20003089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
